Released: ·Last reviewed: ·Prices re-read October 15, 2026 (rows marked)·Methodology v4.1
LillyDirect vs NovoCare Pharmacy: pricing, doses and services compared
LillyDirect and NovoCare Pharmacy serve different priorities. LillyDirect: Eli Lilly selling direct. Brand Zepbound at $299 (2.5mg), $399 (5mg) and $449 (7.5–15mg), re-read October 15… NovoCare Pharmacy: Novo Nordisk selling direct. The Wegovy pill is $149 at 1.5 mg, $199 at 4 mg and $299 at 9 and 25 mg; the Wegovy pen… There is no universal winner — the right choice depends on whether you optimize for lowest starter price, flat dose pricing, or bundled clinical services. Prices marked October 15, 2026 were re-read that day; other fields are from the July 12, 2026 review.
How do they compare, field by field?
| Factor | LillyDirect | NovoCare Pharmacy |
|---|---|---|
| Starting price | $149/mo Foundayo 0.8 mg (archived Sep 25); Zepbound from $299, read Oct 15 Verified Oct 15 | $149/mo Wegovy pill 1.5 mg ($199 at 4 mg), read Oct 15 Verified Oct 15 |
| Renewal price | $299–$449 (Zepbound) Verified | $349/mo (Wegovy injectable) Verified |
| Highest-dose price | $449 with 45-day refill; $499–$699 without Verified | $399 Wegovy HD; $499 Ozempic 2mg Verified |
| Membership | $0 Verified | $0 Verified |
| Labs | None — medication only Verified | None — medication only Verified |
| Shipping | Free Verified | Free Verified |
| Commitment | None Verified | None Verified |
| Pharmacy | LillyDirect Pharmacy (NPI 1912889320) Verified | NovoCare Pharmacy (NPI 1710671854) Verified |
| Clinician | None — bring your own prescription Verified | None — bring your own prescription Verified |
| States | Nationwide; Walmart and Amazon Pharmacy pickup Verified | Nationwide; CVS pickup Verified |
Which one wins on each decision factor?
Each factor below is measured from the providers’ own pages read on October 15, 2026, and the numbers are shown so you can check them. Where one program wins every factor, it is because the other printed a higher price or no price at all; the limitations sections above still apply.
| Decision factor | Better fit |
|---|---|
| Lower standing monthly price (lowest plan, Oct 15) | NovoCare (brand Wegovy pill) ($149 vs $299) |
| Lower month-to-month price (Oct 15) | NovoCare (brand Wegovy pill) ($149 vs $299) |
| Names its dispensing pharmacy on its pages | Both |
| States the same price at every dose | Neither |
LillyDirect: who it fits
Eli Lilly selling direct. Brand Zepbound at $299 (2.5mg), $399 (5mg) and $449 (7.5–15mg), re-read October 15, 2026. Foundayo, Lilly's FDA-approved oral GLP-1, starts at $149/month (archived September 25 page). Guaranteed authentic, no telehealth markup, and quality-verified by the FDA. Limitation: Medication only — no clinical care, and you must bring a prescription. The $449 maintenance rate requires refilling within 45 days of the previous DELIVERY or it rises to $499–$699. Foundayo escalates to $199, $299 and $349 by dose. Full LillyDirect review →
NovoCare Pharmacy: who it fits
Novo Nordisk selling direct. The Wegovy pill is $149 at 1.5 mg, $199 at 4 mg and $299 at 9 and 25 mg; the Wegovy pen is $349, with $199 for the first two fills for new patients through December 31, 2026 (read October 15, 2026). Limitation: Medication only — no clinical care. You must bring a prescription. Full NovoCare Pharmacy review →
Frequently asked questions
Is LillyDirect or NovoCare Pharmacy cheaper?
On starting price: LillyDirect is $149/mo Foundayo 0.8 mg (archived Sep 25); Zepbound from $299, read Oct 15 and NovoCare Pharmacy is $149/mo Wegovy pill 1.5 mg ($199 at 4 mg), read Oct 15. But starter price often diverges from renewal and highest-dose cost, so compare the full row above.
How were these figures verified?
Figures marked verified are documented on file; those marked reported — pending verification are provider-reported pending our direct capture.
Sources
- Both providers' pricing and terms pages, captured July 12, 2026.
- Our price-normalization methodology.
- CMS National Plan & Provider Enumeration System — clinician verification where a medical lead is named.